{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:07:01Z","timestamp":1761988021930,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.freeradbiomed.2005.02.007","type":"journal-article","created":{"date-parts":[[2005,3,5]],"date-time":"2005-03-05T07:11:39Z","timestamp":1110006699000},"page":"1471-1483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Valproic acid glucuronidation is associated with increases in 15-F2t-isoprostane in rats"],"prefix":"10.1016","volume":"38","author":[{"given":"Vincent","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Wei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stoyan","family":"Karagiozov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas K.H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank S.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840020513","article-title":"Valproate-induced hepatic injury: analysis of 23 fatal cases","author":"Zimmerman","year":"1982","journal-title":"Hepatology"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib2","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/0006-2952(83)90054-0","article-title":"The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats","volume":"32","author":"Turnbull","year":"1983","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0006-291X(83)80205-8","article-title":"Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes","volume":"115","author":"Coude","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib4","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.1840040610","article-title":"The hepatotoxicity of valproic acid and its metabolites in rats: II. Intermediary and valproic acid metabolism","volume":"4","author":"Granneman","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib5","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.1840040609","article-title":"The hepatotoxicity of valproic acid and its metabolites in rats: I. Toxicologic, biochemical and histopathologic studies","volume":"4","author":"Kesterson","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib6","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1111\/j.1528-1157.1987.tb05768.x","article-title":"Hepatic considerations in the use of antiepileptic drugs","volume":"28","author":"Dreifuss","year":"1987","journal-title":"Epilepsia"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.39.2.201","article-title":"Valproic acid hepatic fatalities: II. US experience since 1984","volume":"39","author":"Dreifuss","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib8","series-title":"Idiosyncratic reactions to valproate: clinical risk patterns and mechanisms of toxicity","first-page":"149","article-title":"Role of N-acetylcysteine in the treatment of valproate hepatotoxicity","author":"Farrell","year":"1991"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib9","series-title":"Idiosyncratic reactions to valproate: clinical risk patterns and mechanisms of toxicity","first-page":"75","article-title":"Free radical scavenging enzyme activity profiles in risk assessment of idiosyncratic drug reactions: probable mechanism for valproate-induced acute pancreatitis and hepatotoxicity","author":"Pippenger","year":"1991"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/j.1552-4604.1984.tb01823.x","article-title":"Protection against sodium valproate injury in isolated hepatocytes by alpha-tocopherol and N,N\u2032-diphenyl-p-phenylenediamine","volume":"24","author":"Buchi","year":"1984","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib11","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1212\/WNL.34.10.1393","article-title":"Selenium, zinc, and copper changes with valproic acid: possible relation to drug side effects","volume":"34","author":"Hurd","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2007-973560","article-title":"Altered antioxidant enzyme activities in children with a serious adverse experience related to valproic acid therapy","volume":"29","author":"Graf","year":"1998","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/phrs.1999.0603","article-title":"The effects of carbamazepine and valproic acid on the erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children","volume":"41","author":"Cengiz","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/088307380101600814","article-title":"Changes in the antioxidant system in epileptic children receiving antiepileptic drugs: two-year prospective studies","volume":"16","author":"Yuksel","year":"2001","journal-title":"J. Child. Neurol."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0006-2952(90)90560-8","article-title":"Early changes in hepatic redox homeostasis following treatment with a single dose of valproic acid","volume":"40","author":"Cotariu","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/phrs.1997.0134","article-title":"Biochemical basis of sodium valproate hepatotoxicity and renal tubular disorder: time dependence of peroxidative injury","volume":"35","author":"Raza","year":"1997","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/JBCPP.2000.11.1.73","article-title":"Erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children with valproate and carbamazepine monotherapy","volume":"11","author":"Yuksel","year":"2000","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1021\/tx9801864","article-title":"Assessing the mechanism of metabolism-dependent valproic acid-induced in vitro cytotoxicity","volume":"12","author":"Tabatabaei","year":"1999","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib19","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","article-title":"A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism","volume":"87","author":"Morrow","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-2697(90)90002-Q","article-title":"Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids","volume":"184","author":"Morrow","year":"1990","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib21","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1172\/JCI116143","article-title":"Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity: an animal model of lipid peroxidation","volume":"90","author":"Morrow","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0005-2760(94)90128-7","article-title":"Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo","volume":"1210","author":"Morrow","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib23","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0891-5849(03)00151-5","article-title":"The effect of valproic acid on hepatic and plasma levels of 15-F(2t)-isoprostane in rats","volume":"34","author":"Tong","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0006-2952(85)90111-X","article-title":"Oxidation and glucuronidation of valproic acid in male rats-influence of phenobarbital, 3-methylcholanthrene, beta-naphthoflavone and clofibrate","volume":"34","author":"Heinemeyer","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0022-3565(25)32938-1","article-title":"Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat","volume":"220","author":"Watkins","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib26","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0006-2952(03)00076-5","article-title":"The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases","volume":"65","author":"Ethell","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0009-2797(00)00198-8","article-title":"Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions","volume":"129","author":"Ritter","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.abb.2004.02.004","article-title":"Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms","volume":"424","author":"Sakaguchi","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0022-3565(25)31879-3","article-title":"Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect","volume":"211","author":"Dickinson","year":"1979","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01073869","article-title":"Physiologic and metabolic influences on enterohepatic recirculation: simulations based upon the disposition of valproic acid in the rat","volume":"19","author":"Pollack","year":"1991","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/hep.1840010411","article-title":"Choleretic effect of valproic acid in the rat","volume":"1","author":"Watkins","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/1389200023337315","article-title":"Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions","volume":"3","author":"Boelsterli","year":"2002","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib33","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0022-3565(24)36958-7","article-title":"Time course of alpha-fluorinated valproic acid in mouse brain and serum and its effect on synaptosomal gamma-aminobutyric acid levels in comparison to valproic acid","volume":"282","author":"Tang","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib34","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/S0024-3205(02)02107-0","article-title":"Inhibition of tubulin assembly and covalent binding to microtubular protein by valproic acid glucuronide in vitro","volume":"71","author":"Cannell","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib35","first-page":"177","article-title":"Valproic acid intoxication identified by 1H and 1H-13C correlated NMR spectroscopy of urine samples","volume":"10","author":"Azaroual","year":"2000","journal-title":"Magma"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1023\/A:1015882607690","article-title":"Validation of bioanalytical methods","volume":"8","author":"Karnes","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1124\/jpet.102.043174","article-title":"In vivo mechanistic studies on the metabolic activation of 2-phenylpropionic acid in rat","volume":"305","author":"Li","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib38","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0022-3565(25)38967-6","article-title":"Depletion of hepatic UDP-glucuronic acid by drugs that are glucuronidated","volume":"236","author":"Howell","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0022-3565(25)12744-4","article-title":"Effect of UDP-glucuronic acid depletion by salicylamide on biliary bilirubin excretion in the rat","volume":"254","author":"Kamisako","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib40","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hep.510230418","article-title":"Hepatobiliary disposition of valproic acid and valproate glucuronide: use of a pharmacokinetic model to examine the rate-limiting steps and potential sites of drug interactions","volume":"23","author":"Booth","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1528-1157.1987.tb03640.x","article-title":"Hepatotoxicity in rat following administration of valproic acid","volume":"28","author":"Sugimoto","year":"1987","journal-title":"Epilepsia"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1212\/WNL.37.3.379","article-title":"Valproic acid hepatic fatalities: a retrospective review","volume":"37","author":"Dreifuss","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/clpt.1990.144","article-title":"Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid","volume":"48","author":"Levy","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib44","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/clinchem\/34.5.890","article-title":"Valproic acid and the liver","volume":"34","author":"Cotariu","year":"1988","journal-title":"Clin. Chem."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib45","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/tx00047a006","article-title":"Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status","volume":"8","author":"Tang","year":"1995","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0300-483X(96)03352-5","article-title":"Cytotoxicity of unsaturated metabolites of valproic acid and protection by vitamins C and E in glutathione-depleted rat hepatocytes","volume":"112","author":"Jurima-Romet","year":"1996","journal-title":"Toxicology"},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0009-9120(01)00217-X","article-title":"CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity","volume":"34","author":"Neuman","year":"2001","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib48","first-page":"1210","article-title":"Effect of alpha-fluorination of valproic acid on valproyl-S-acyl-CoA formation in vivo in rats","volume":"29","author":"Grillo","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib49","doi-asserted-by":"crossref","first-page":"PL141","DOI":"10.1016\/0024-3205(93)90279-C","article-title":"Predictability of the covalent binding of acidic drugs in man","volume":"53","author":"Benet","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0009-2797(03)00020-6","article-title":"Acyl glucuronide reactivity in perspective: biological consequences","volume":"145","author":"Bailey","year":"2003","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib51","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0006-2952(92)90239-F","article-title":"Studies on the reactivity of acyl glucuronides: III. Glucuronide-derived adducts of valproic acid and plasma protein and anti-adduct antibodies in humans","volume":"43","author":"Williams","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0090-9556(25)07712-8","article-title":"pH-dependent rearrangement of the biosynthetic ester glucuronide of valproic acid to beta-glucuronidase-resistant forms","volume":"12","author":"Dickinson","year":"1984","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/B:MCBI.0000021341.38630.52","article-title":"Glucuronic acid is a novel inducer of heat shock response","volume":"259","author":"Kim","year":"2004","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0009-2797(00)00253-2","article-title":"Methapyrilene hepatotoxicity is associated with increased hepatic glutathione, the formation of glucuronide conjugates, and enterohepatic recirculation","volume":"129","author":"Ratra","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib55","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0041-008X(82)90240-X","article-title":"Induction studies on the functional heterogeneity of rat liver UDP-glucuronosyltransferases","volume":"64","author":"Watkins","year":"1982","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2005.02.007_bib56","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1124\/jpet.103.064220","article-title":"Abolition of valproate-derived choleresis in the mrp2 transporter-deficient rat","volume":"310","author":"Wright","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584905000638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584905000638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:57:15Z","timestamp":1760198235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584905000638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0891584905000638"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2005.02.007","relation":{},"ISSN":["0891-5849"],"issn-type":[{"type":"print","value":"0891-5849"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid glucuronidation is associated with increases in 15-F2t-isoprostane in rats","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2005.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}